Form 4: CorMedix Director Steven W. Lefkowitz Exercises Stock Options
SEC Form 4 Filing
Director Steven W. Lefkowitz acquired 20,000 shares of CorMedix Inc. common stock through the exercise of stock options on April 2, 2025.
Summary
- On April 2, 2025, Steven W. Lefkowitz, a director of CorMedix Inc., exercised stock options to acquire 20,000 shares of common stock at a price of $4.03 per share.
- Following the transaction, Lefkowitz directly owns 120,498 shares of CorMedix Inc. common stock.
- Lefkowitz also indirectly owns 30,152 shares through Wade Capital Corporation Money Purchase Plan and 2,000 shares through his wife.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a routine disclosure of stock option exercise.
Positives
- The exercise of stock options by a director could be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
This is a standard SEC Form 4 filing, which is common for corporate insiders who have transactions in their company's stock. It provides transparency to the market regarding insider activity.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding insider activity.
Key Dates
| Date | Description |
|---|---|
| 02/22/2022 | Date stock options were granted. |
| 04/02/2025 | Date of transaction (exercise of stock options). |
| 04/03/2025 | Date of signature on the Form 4. |
Keywords
CorMedix, CRMD, Steven Lefkowitz, stock options, Form 4, beneficial ownership, director, securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.